Patient Support

The KineretKare™ Program

KineretKare is a comprehensive patient support program designed to assist you with your Kineret® prescription.

 

What does this program offer?

  • Helps you navigate insurance barriers
  • Co-pay assistance to offset out-of-pocket costs, if you are eligible
  • Delivery of your medication directly to your home or office

 

You can save up to $300/month or $3600/year in co-pay/out-of-pocket costs.

 

In order to receive co-pay is assistance, you must meet the following criteria:

  • Not currently receive healthcare coverage through Medicare, Medicaid, or other federal or state programs
  • Co-pay/out-of-pocket cost above $25 for a 30-day supply of Kineret®
  • Other restrictions may apply—call the KineretKareTM Team at the number below or visit KineretRx.com for more information

 

If you don’t qualify for this program, ask the KineretKareTM Team about other programs that may be able to help. 

 

You can reach a KineretKareTM specialist at 1-866-547-0644, Monday through Friday 8:00 AM - 6:00 PM EST. 

Click below to download:

 

KineretKare Enrollment Form                                       Patient Assistance Form
                                               

 

Register for more information on Kineret® or tell us your story.

Please fill out the form and click “submit” to receive updates on Kineret® or to volunteer to tell us your story. Fields marked with * are mandatory.

 
Please choose one of the options:*
Swedish Orphan Biovitum ("Sobi") understands your personal and health information is private. The information you provide will only be used by Sobi and parties acting on its behalf to send you materials and other helpful information and updates on Kineret and/or RA as well as related treatments, products, offers and services.

Frequently Asked Questions about Reimbursement Services

How long will it take before I hear back on coverage decisions?

Insurance benefits coverage is verified within 24-48 hours.

How will I hear back regarding coverage decisions?

Your healthcare provider is notified via fax; you can contact your provider.

What if the coverage request is denied and an appeal is necessary?

We will contact the insurance company for procedures and discuss next steps with your physician.

What if a prior authorization is necessary?

We will contact the insurance company for procedures and discuss next steps with your physician.

Frequently Asked Questions about the Patient Assistance Program

What should I send in as proof of income?

Copy of your most recent federal (ie, IRS Form 1040) or state tax return, latest W-2 statement, SSDI/SSI award letter, last 3 months of bank statements showing income deposits, or last 2 pay stubs.

What if I don’t have proof of income?

You may complete ONE of the following forms ‐ notarized income statement or attestation statement of income with 2 signatures, furnished on request.

Can the application, prescription, and proper documentation be faxed?

Yes; however, faxed prescriptions must be received directly from your doctor’s office with a valid fax banner.

What prescription form should New York or New Jersey prescribers use?

New York and New Jersey prescribers should use an original New York State or New Jersey State Prescription Form.

If I’m denied enrollment, can I appeal?

Yes – appeals must be submitted in writing, along with the denied application and related documentation. Hardship appeals will be considered on a case‐by‐case basis.

How is my prescription shipped?

Prescriptions of Kineret® are shipped cold packed via FedEx overnight delivery, with signature required, to your home.

How long will it take for benefits to be verified?

The benefits verification process takes 24‐48 hours.

How can I obtain a copy of the Patient Assistance application for Kineret?

Click here <link to PAP Form - updated version will soon be available from Sobi> to download the Patient Assistance Form.

Speak to a
KineretKare™ Specialist
866.547.0644
866.549.7219

INDICATION

Kineret® (anakinra) for injection, for subcutaneous use, is an interleukin-1 receptor antagonist (IL-1ra) used to:

  • Reduce the signs and symptoms, and slow the damage of moderate to severe active rheumatoid arthritis (RA) in people age 18 years and older when 1 or more other drugs for RA have not worked. Kineret is not for children with Juvenile Rheumatoid Arthritis.
  • Treat people with the severe form of Cryopyrin-Associated Periodic Syndromes (CAPS) called Neonatal-Onset Multisystem Inflammatory Disease (NOMID).

 

 

IMPORTANT SAFETY INFORMATION

Do not take Kineret if you have an allergy to:

  • proteins made from bacterial cells (E. coli). Ask your healthcare provider if you are not sure.

  • any of the ingredients in Kineret. See the end of the patient leaflet for a complete list of ingredients in Kineret.



Before taking Kineret, tell your healthcare provider if you:


  • have an infection, a history of infections that keep coming back or other problems that can increase your risk of infections.

  • have an allergy to rubber or latex. The needle cover on the prefilled syringe contains latex. Do not handle the needle cover if you are allergic to latex.

  • have kidney problems.

  • are scheduled to receive any vaccines. People using Kineret should not receive live vaccines.

  • are pregnant or plan to become pregnant. It is not known if Kineret will harm your unborn baby.

  • are breastfeeding or plan to breastfeed. It is not known if Kineret passes into your breast milk. You and your healthcare provider should decide if you will take Kineret or breastfeed.



Tell your healthcare provider about all the medicines you take, including prescription and non-prescription medicines, vitamins and herbal supplements. Tell your healthcare provider if you take other medicines that affect your immune system.
Especially tell your healthcare provider if you use: ENBREL® (etanercept), HUMIRA® (adalimumab), or REMICADE® (infliximab).


Kineret may cause serious side effects, including:

  • serious infections. Kineret may lower your ability to fight infections. During treatment with Kineret, call your healthcare provider right away if you get an infection, have any sign of an infection including a fever, chills, or have any open sores on your body.
  • low white blood cell count (neutropenia). Kineret may cause you to have a lower number of certain white cells (neutrophils). Neutrophils are important in fighting infections. You should have blood tests before starting treatment with Kineret, then monthly for 3 months. After the first 3 months you should have your blood tested every 3 months for up to 1 year.
  • allergic reactions. Stop using Kineret and call your healthcare provider or get emergency help right away if you have any of these symptoms of an allergic reaction: swelling of your face, lips, mouth or tongue; trouble breathing; wheezing; severe itching; skin rash, redness, or swelling outside of the injection site area; dizziness or fainting; fast heartbeat or pounding in your chest (tachycardia); or sweating.


 The most common side effects of Kineret include:

  • injection site skin reactions, including redness, swelling, bruising, itching, and stinging. Most injection site reactions are mild, occur early during treatment, and last about 2-4 weeks. Injection site reactions have been observed less frequently in people with NOMID.
  • headache
  • nausea and vomiting
  • joint pain
  • fever
  • feeling like you have the flu
  • sore throat or runny nose
  • sinus infection
  • pain in your stomach area

These are not all of the possible side effects of Kineret. Tell your healthcare provider if you have any side effect that bothers you or does not go away. For more information ask your healthcare provider or pharmacist.

Enbrel® is a registered trademark of Immunex Corporation, Thousand Oaks, Ca.
Remicade® is a registered trademark of Centocor, Inc., Malvern, Pa.
Humira® is a registered trademark of Abbott Laboratories, Abbot Park, Il.